Zhang Jinlan
Date:2026-3-18 16:05:44 Views:
Zhang Jinlan, Deputy Director of the Division of Drug Analysis, Institute of Materia Medica, Chinese Academy of Medical Sciences, and Deputy Chair of the Department of Pharmaceutical Analysis, Peking Union Medical College.
She has led more than ten major research projects, including General Program projects funded by the National Natural Science Foundation of China and projects under the National Major New Drug Innovation Program. As an academic leader in pharmaceutical analysis, she focuses on the development and application of novel analytical techniques and methodologies. She has completed preclinical quality analysis and metabolism studies for three Category 1 innovative drugs, facilitating their approval for clinical trials, which are currently underway.
Addressing longstanding challenges in impurity identification and control that affect the quality and safety of widely used clinical drugs in China, she has established a rapid analytical and identification system for impurities in high-risk clinical drugs. Her work has contributed to the revision of quality control standards for drugs such as methotrexate.
She pioneered internationally advanced analytical technologies for complex pharmaceutical excipients, including polysorbates and lipid-based excipients, and successfully developed the first automated analysis software for pharmaceutical excipients both in China and internationally. She has also established a rapid screening and evaluation system for genotoxic impurities in chemical drugs, supporting the development of quality standards for generic drug consistency evaluation and innovative drugs in China.
Under her leadership, the Division of Drug Analysis provided technical support for the expansion of doping detection capabilities during the 2008 Beijing Olympic Games and the 2022 Beijing Winter Olympics. The Guiding Principles for Proteomics Analysis Methods and Applications, which she led in drafting, has been incorporated into the 2025 edition of the Chinese Pharmacopoeia, providing important standards and technical support for the pharmaceutical industry. She is a recipient of the First Prize of the Higher Education Science and Technology Award (Natural Sciences).
